The IL6-STAT3 signaling pathway is essential in the inflammatory response of tumor tissues, and the IL6- STAT3 signaling pathway has been reported to promote the enrichment of PCSCs in PCa tissues treated with ADT [32]. Here, IL6 is linked to neoplasm.